| Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma (NCT05932199) | Baylor College of Medicine | 2024-07-03 |
| A Study to Compare and Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of UI059 and UIC202201 (NCT06393881) | Korea United Pharm. Inc. | 2024-07-03 |
| Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer (NCT06515470) | Biotheryx, Inc. | 2024-07-03 |
| TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia (NCT06088888) | Shenzhen TargetRx Co., Ltd. | 2024-07-02 |
| CD40 Agonist and PD-1 Inhibitor in HNSCC (NCT06159621) | University of Pennsylvania | 2024-07-02 |
| Improving Perioperative Sleep Disorders (NCT06512155) | Mengchang Yang | 2024-07-02 |
| A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1) (NCT06431594) | GlaxoSmithKline | 2024-07-02 |
| A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors (NCT06474455) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-07-02 |
| A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers (NCT06398730) | GE Healthcare | 2024-07-02 |
| Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa (NCT06591793) | AAVantgarde Bio Srl | 2024-07-02 |
| A Study in Healthy People to Compare Two Different Sifrol® Tablets (NCT06457204) | Boehringer Ingelheim | 2024-07-02 |
| Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis (NCT06569472) | Chongqing Precision Biotech Co., Ltd | 2024-07-02 |
| Delta-8-THC vs. Delta-9-THC on Simulated Driving Performance (NCT06218550) | Johns Hopkins University | 2024-07-01 |
| MRI-Guided Ultrasound Stimulated Microbubbles Radiation Treatment for Patients with Chest-Wall and Locally Advanced Breast Cancer (NCT06633601) | Sunnybrook Health Sciences Centre | 2024-07-01 |
| Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents (NCT05013983) | WestVac Biopharma Co., Ltd. | 2024-07-01 |
| Eculizumab for Prevention of Antibody-Mediated Rejection in ABO-Incompatible Living Donor Kidney Transplantation (NCT06453135) | Tao Lin | 2024-07-01 |
| A Study Evaluating Multiple Ascending Doses of QRL-101 in Healthy Participants (NCT06532396) | QurAlis Corporation | 2024-07-01 |
| Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection (NCT06678113) | Biosergen AS | 2024-07-01 |
| Rezafungin Pharmacokinetics in Patients on ECMO (NCT06329518) | Hartford Hospital | 2024-07-01 |
| Bioequivalence Study of Sulfadoxine/Pyrimethamine 500/25 mg Dispersible Tablet (NCT06522763) | Swiss Pharma Nigeria Limited | 2024-07-01 |
| Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT (NCT06505759) | Krishnadevaraya College of Dental Sciences & Hospital | 2024-07-01 |
| GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors (NCT06435455) | Suzhou Genhouse Bio Co., Ltd. | 2024-07-01 |
| Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES) (NCT06252727) | University of California, Davis | 2024-07-01 |
| A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy (NCT06525272) | Healthgen Biotechnology Corp. | 2024-07-01 |
| Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer (NCT06527898) | Anhui Provincial Hospital | 2024-07-01 |
| Protocols for Magnesium Sulfate Maintenance Dose in Overweight and Obese Women Diagnosed With Preeclampsia (NCT06486025) | Ain Shams University | 2024-07-01 |
| Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia (NCT06482541) | Levit Dermatology | 2024-07-01 |
| A Safety and Tolerability Study of Jaktinib (NCT05279001) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2024-07-01 |
| Evaluating Safety and Efficacy of Autologous Gene-edited Muscle Stem Cells (GenPHSats-bASKet) (NCT05588401) | Simone Spuler, MD | 2024-07-01 |
| Trial of INI-4001 in Patients With Advanced Solid Tumours (NCT06302426) | Inimmune Corporation | 2024-07-01 |
| Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia (NCT05469828) | Children's Hospital Los Angeles | 2024-07-01 |
| A Study to Assess the Safety and Pharmacokinetics of a Single Dose of UCB9741 in Healthy Caucasian and Japanese Participants (NCT06315335) | UCB Biopharma SRL | 2024-07-01 |
| A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1) (NCT06470763) | Anaveon AG | 2024-07-01 |
| A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (NCT06054893) | Biogen | 2024-07-01 |
| IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations (NCT06487377) | Shanghai Pudong Hospital | 2024-07-01 |
| Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT (NCT07062523) | Peking Union Medical College Hospital | 2024-07-01 |
| A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus (NCT06518668) | Hospital for Special Surgery, New York | 2024-07-01 |
| The Effectiveness of Probiotics in Neonatal Jaundice (NCT06449508) | Tanta University | 2024-07-01 |
| Efficacy of Formulated Eggshell Derived Nano-hydroxyapatite Containing Toothpaste With and Without Addition of Fluoride vs. Conventional Desensitizing Fluoride Containing Toothpaste in Management of Dentin Hypersensitivity (NCT06493500) | Cairo University | 2024-07-01 |
| A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects (NCT06537050) | Zhejiang Jingxin Pharmaceutical Co., Ltd. | 2024-07-01 |
| Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma (NCT06461624) | Zhejiang University | 2024-07-01 |
| A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC (NCT06478693) | Myeloid Therapeutics | 2024-07-01 |
| An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers (NCT06510413) | Frontier Biotechnologies Inc. | 2024-07-01 |
| Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults (NCT06441968) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-07-01 |
| A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis (NCT06469164) | BioNTech SE | 2024-07-01 |
| to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection (NCT06437951) | Daewoong Pharmaceutical Co. LTD. | 2024-07-01 |
| MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction (NCT07183384) | Universitas Padjadjaran | 2024-07-01 |
| Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations (NCT06080165) | Stanford University | 2024-07-01 |
| Flumazenil Antagonism of Remimazolam in Kidney Transplant Patients (NCT06531369) | Qianfoshan Hospital | 2024-07-01 |
| Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Japanese Persons (NCT06515834) | Ferring Pharmaceuticals | 2024-07-01 |
| A Study of PHN-010 in Patients With Advanced Solid Tumors (NCT06457997) | Pheon Therapeutics | 2024-07-01 |
| Modified Periosteal Inhibition with Simultaneous Implant Placement in Aesthetic Zone (NCT06519773) | Tanta University | 2024-07-01 |
| Dexamethasone/Pancreatic Clamp P&F (NCT06126354) | Columbia University | 2024-07-01 |
| A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma (NCT06494371) | Ruijin Hospital | 2024-07-01 |
| Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers (NCT06136195) | Yale University | 2024-07-01 |
| Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC (NCT06456138) | Shanghai Chest Hospital | 2024-07-01 |
| Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients (NCT06551064) | Formycon AG | 2024-07-01 |
| Effect of Single-versus Double-limb Cycling Exercise on Blood Flow in Patients With Peripheral Artery Disease (NCT06518590) | Cairo University | 2024-07-01 |
| A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (NCT06465069) | Eli Lilly and Company | 2024-07-01 |
| Cardiovascular Genistein Therapy for Heart Failure Inflammation (NCT06501768) | University Medical Centre Ljubljana | 2024-07-01 |
| Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma (NCT06463522) | Beijing 302 Hospital | 2024-07-01 |
| A Study to Learn About the Taste of Vericiguat Given in Liquid Form in Healthy Male Participants Aged 18 to 45 Years (NCT06474208) | Bayer | 2024-07-01 |
| Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity (NCT05741606) | Tabriz University of Medical Sciences | 2024-07-01 |
| A Study To Evaluate The Effect Of Rifampicin Or Ltraconazole On Pharmacokinetics Of Ensartinib In Healthy Volunteers (NCT06492525) | Betta Pharmaceuticals Co., Ltd. | 2024-07-01 |
| Bioequivalence Study of Empagliflozin 25 mg Film-coated Tablets in Healthy Thai Volunteers (NCT06337409) | International Bio service | 2024-07-01 |
| Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART (NCT06430905) | Hookipa Biotech GmbH | 2024-07-01 |
| A Phase I, the Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002 (NCT06162299) | Yisheng Biopharma (Singapore) Pte. Ltd. | 2024-07-01 |
| SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection (NCT03217617) | Shenzhen Geno-Immune Medical Institute | 2024-06-30 |
| A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation (NCT06441084) | Nuwacell Biotechnologies Co., Ltd. | 2024-06-30 |
| Effect of Vitamin D Supplementation on Mental Health: An Exploratory Study on A University Students Suffering From Vitamin D Deficiency (NCT06458686) | German University in Cairo | 2024-06-30 |
| 89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic Sclerosis (NCT06489652) | Jiangsu Renocell Biotech Company | 2024-06-30 |
| Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors (NCT06462222) | Guangzhou Medical University | 2024-06-30 |
| Phase I Clinical Trial of UC-MSCs in the Treatment of Knee Osteoarthritis (NCT06463847) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-06-30 |
| Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread (NCT06324357) | Boehringer Ingelheim | 2024-06-28 |
| Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) (NCT06458595) | Chengdu Origen Biotechnology Co., Ltd. | 2024-06-28 |
| A Study to Assess the Abuse Potential of Intranasal Cebranopadol (NCT06453265) | Tris Pharma, Inc. | 2024-06-28 |
| PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer. (NCT06369246) | M.D. Anderson Cancer Center | 2024-06-27 |
| CAN1012 Combined With PD-1 in Patients With Solid Tumors (NCT06410703) | Canwell Biotech Limited | 2024-06-27 |
| Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (NCT06491134) | Hebei Medical University Fourth Hospital | 2024-06-27 |
| Modulation of THC Effects by CBD: a Dose-ranging Study (NCT06099379) | Centre hospitalier de l'Université de Montréal (CHUM) | 2024-06-27 |
| A First In Human (FIH) Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults (NCT06452771) | Regeneron Pharmaceuticals | 2024-06-27 |
| A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors (NCT06469008) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-06-27 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of Single Doses of BMS-986435 (MYK-224) in Healthy Chinese Participants (NCT06476821) | Bristol-Myers Squibb | 2024-06-27 |
| Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery (NCT06349590) | University of Chicago | 2024-06-27 |
| A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors (NCT06413953) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-06-27 |
| Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells (NCT06347068) | UNC Lineberger Comprehensive Cancer Center | 2024-06-27 |
| Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation (NCT06298357) | University of Alabama at Birmingham | 2024-06-27 |
| A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. (NCT06447662) | Pfizer | 2024-06-27 |
| A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity (NCT06478563) | Novo Nordisk A/S | 2024-06-27 |
| An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases (NCT06464679) | Changhai Hospital | 2024-06-27 |
| A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors (NCT06452160) | BridGene Biosciences Inc. | 2024-06-27 |
| A Trial of SHR-4849 in Advanced Solid Tumors (NCT06443489) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2024-06-26 |
| A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis (NCT07051538) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-06-26 |
| A Study of Calderasib (MK-1084) Human Absorption, Distribution, Metabolism, and Excretion in Healthy Adult Participants (MK-1084-006) (NCT06687759) | Merck Sharp & Dohme LLC | 2024-06-26 |
| Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults (NCT06444048) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-06-26 |
| TGRX-326 Pharmacokinetic Mass Balance (NCT06438367) | Shenzhen TargetRx Co., Ltd. | 2024-06-26 |
| Safety of Bryostatin in Patients With MS (NCT06190912) | Robert Fox | 2024-06-26 |
| Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC (NCT06494943) | Fudan University | 2024-06-26 |
| First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP (NCT06460064) | Sumitomo Pharma Co., Ltd. | 2024-06-26 |
| Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies (NCT06383572) | M.D. Anderson Cancer Center | 2024-06-26 |